Formulating and Analyzing Box-Behnken-designed Sustained Release Beads for Perindopril Erbumine

Vanshika Sahu¹*, Mayuri Pawar¹, Nikita Wakchaware¹, Mayuri Shrikhande²

¹Department of Pharmaceutics, Dr. Rajendra Gode College of Pharmacy, Amravati, Maharashtra, India.

²Department of Pharmaceutical Chemistry, Dr. Rajendra Gode College of Pharmacy,

Amravati, Maharashtra, India.

*Corresponding Author E-mail: vanshikasahu347@gmail.com

ABSTRACT:

The target of the current project was to arranged microbeads of perindopril erbumine to accomplish supported activity and furthermore to forestall the various dosing of the medication. The review meant to make microbeads for supported drug discharge and lessen dosing recurrence. Utilizing FT-IR and DSC studies, it was found that the medication and polymers utilized didn't inconsistently. The micromeritics concentrate on uncovered great flowability, while the SEM concentrate on uncovered round particles however unpleasant surface with breaks. The in-vitro study showed that the supported medication discharge impacted the polymer fixation. The upgraded detailing was B20, with most extreme medication discharge during 12 hours. The medication discharge was preferable in basic mediums over acidic ones. The cross-connecting specialist glutaraldehyde was viewed as the best in relieving the dabs, influencing rigidization. The medication discharge followed zero request energy with super case-II vehicle and a fickian dispersion technique. The plan was steady under different circumstances and assessment boundaries.

KEYWORDS: Perindopril Erbumine, Microbeads, Controlled Drug Delivery, Box-Behnken Design.

INTRODUCTION:

Controlled drug distribution methodology enhances effectiveness, reduces toxicity, and provides convenience by using tiny molecules to deliver medications, improving drug availability and reducing bioavailability. Unit dose structures like microspheres or miniature globules are popular oral medication delivery frameworks due to their consistent dissemination, retention, and reduced local irritation.

Microbeads are small, strong, free-streaming particulate transporters that allow delayed or different treatment delivery without significant negative impacts.^1-3The study aims to develop a controlled release dose form for Perindopril Erbumine, an angiotensin converting enzyme inhibitor, to improve its bioavailability and effectiveness.^4-9.

MATERIALS AND METHODS:

A free sample of Perindopril Erbumine was received from Lara Drugs Pvt. Ltd, Hyderabad, India. We purchased sodium alginate from Loba Chem, Poliglusam from Yarrow Chem, Glutaraldehyde and Zinc Sulfate from S.D. Fine Chem. Any remaining mixtures were analytical.

Preparation with its Isolation of Tintiri Mucilage: Tintiri seeds were sun-dried till dry. The dried seeds were agitated in boiling water for up to 6 hours to extract mucilage and render the water whitish-brown. The solution was refrigerated overnight to settle particulates. Following day, a cotton cloth filtered the solution till it was completely filtered. Mucilage was isolated from the filtrate by treating it with pure acetone. After one more CH3)2CO wash, the gum was dried at room temperature for 24 hours¹⁰. After drying, the gum was crushed and filtered through a #10 sieve and kept in a desiccator.

Standard Calibration Curve: 100mg of Perindopril Erbumine was painstakingly weighed into a 100ml standard flagon and volume was changed with pH 6.8 phosphate cradle. Aliquots of 0.5 to 5ml were pipetted into 10ml volumetric carafes from an answer with a convergence of 100μg the volume was changed with phosphate support 6.8 to accomplish groupings of expanding way 5 to 50μg/ml ^11-13. The absorbance of every fixation was 215nm.

Optimization of Beads: Improving Three-factor, one-reaction plans are really great for examining quadratic reaction surfaces and building second-request polynomial models with Plan Master. For the purpose of obtaining the regression equations, linear and second-order polynomials were fitted to the experimental data.

Table 1: Detailing of Trial Levels for a Number of Different Process Parameters

Factors	Level Used
A. Sod Alginate (% w/v)	2	4	6
B. Tintiri Mucilage (% w/v)	2	4	6
C. ZnSO₄ (% w/v)	10	15	20
A. Sod Alginate and Tintiri Mucilage (% w/v)	2:6	4:4	6:2
B. Poliglusam (% w/v)	2	4	6
C. Glutaraldehyde (% w/v)	7.5	10	12.5

Fabrication of Beads:

The study aimed to optimize the production of drug-loaded beads by creating blank beads with different concentrations of sodium alginate and zinc sulphate. The beads were then used to create drug-loaded ones. The process involved a magnetic stirrer, dissolved sodium alginate, Tintiri mucilage, and medication in distilled water, and zinc sulphate. The mixture was then mixed with Poliglusam arrangement, causing ionotropic gelation. The beads were then filtered, washed, and dried at room temperature for 12 hours. Glutaraldehyde cross-linked the bead. The beads were evenly distributed in a petri plate and stored in glutaraldehyde-filled desiccators. The beads were glutaraldehyde-treated for 4 hours.¹⁴

Table 2: Chart for Preparing Perindopril Erbumine Microbeads

Batch	Drug (mg)	Sodium Alginate (%w/v)	Tintiri Mucilage (%w/v)	Zinc Sulphate (%w/v)	Sodium alginate and Tintiri Mucilage (%w/v)	Poliglusam (%w/v)	Glutaraldehyde (%w/v)
B1	4	4	4	15	-	-	-
B2	4	2	6	15	-	-	-
B3	4	6	2	15	-	-	-
B4	4	6	4	20	-	-	-
B5	4	2	4	20	-	-	-
B6	4	6	6	15	-	-	-
B7	4	4	6	10	-	-	-
B8	4	2	4	10	-	-	-
B9	4	6	4	10	-	-	-
B10	4	2	2	15	-	-	-
B11	4	4	6	20	-	-	-
B12	4	4	2	20	-	-	-
B13	4	4	2	10	-	-	-
B14	4	-	-	-	4:4	4	10
B15	4	-	-	-	2:6	6	10
B16	4	-	-	-	6:2	2	10
B17	4	-	-	-	6:2	4	12.5
B18	4	-	-	-	2:6	4	12.5
B19	4	-	-	-	6:2	6	10
B20	4	-	-	-	4:4	6	7.5
B21	4	-	-	-	2:6	4	7.5
B22	4	-	-	-	6:2	4	7.5
B23	4	-	-	-	2:6	2	10
B24	4	-	-	-	4:4	6	12.5
B25	4	-	-	-	4:4	2	12.5
B26	4	-	-	-	4:4	2	7.5

Evaluation Parameters:

Micromeritics Properties: The micromeretic parameters of the produced microbeads, including Tap density, Bulk density, Hauser's ratio, Carr's index, and Angle of repose, were assessed.¹⁵

Drug Entrapment Efficiency:

Dots that had been unequivocally gauged adding up to ten milligrams were put to a container that contained ten milliliters of phosphate cushion with a pH of 6.8. The blend was then passed on to represent 24hours. Utilizing an attractive stirrer, the items in the measuring utencil were fomented for one to two hours to break the globules totally. From that point forward, the dots were separated utilizing which man channel paper. A bright noticeable spectrophotometer was utilized to gauge the absorbance at 215nm to show up at a gauge of how much medicine (x) that was available in a solitary bunch of dabs before it was sifted through. To decide the adequacy of medication capture, the accompanying equations were used:

% Medicament Entrapment efficiency = (AD /DT) *100

Where, AD = Genuine amount of medication present in globules and DT = Hypothetical amount of medication added during readiness

Swelling Index: A recepticle with 10 milliliters of phosphate cradle with a pH of 7.4 and 0.1 N hydrochloric corrosive was set up with prepared dots. The mixture was left at room temperature for six hours, excess fluid was removed, and extended globules were weighed. Three different results were obtained from each trial. By applying the accompanying equation, we had the option to decide the expanding record of the globules:

SI= (SB-DB)/ Wd

Where, SB= weight of enlarged globules & DB= weight of dried dabs

Percentage Yield:

Weighing the microbeads after they had been dried allowed us to calculate the percentage yield of the microbeads formulation that had been created. The genuine load of the microbeads was separated by the absolute weight of the multitude of non-unstable parts that were used in the assembling of the microbeads, and the outcome was resolved utilizing the recipe that is introduced underneath:

Genuine Weight of microbeads

Percentage Yield = ---------------------------------------------- × 100

Hypothetical Weight of microbeads

Bead Size Determination:

To decide the size of the alginate globules, an optical magnifying instrument and a compound magnifying instrument were used. During the alignment cycle of the optical micrometer, a standard stage micrometer was used.

Loose surface crystal study (LSC):

This examination was completed fully intent on deciding the amount of the medicine that was found on the outer layer of the microbeads, which showed a prompt delivery when set in dissolving media. To reenact the dissolving medium, 100 milligrams of microbeads were suspended in 100 milliliters of phosphate support with a pH of 7.4. Inside a mechanical shaker, the examples were strongly shaken for a time of fifteen minutes. The spectrophotometric examination was performed at 215 nm to decide the amount of medicine that had filtered off from the surface.^16-19

Surface Morphology:

The filtering electron microscopy (SEM) method was used to learn the surface morphology of the microbeads that were developed. To set up the examples for examining electron microscopy (SEM), the microbeads were sprinkled over a twofold sticky tape that was stuck to a stub. Hence, the stubs were covered with platinum while being presented to a climate of argon. This was achieved by using a gold falter module inside an extremely high vacuum evaporator.

In vitro drug release:

Investigations of the in-vitro arrival of delivered dabs were completed in 900 milliliters of 0.1 N hydrochloric corrosive with a pH of 1.2. The examination was directed in 0.1 N hydrochloric corrosive for a term of two hours, trailed by the utilization of phosphate cradle for the excess span (pH 7.4). The contraption used was USP-XXII, and it pivoted at a speed of 100 cycles each moment. The temperature was kept up with at 37±5 degrees Celsius for a length of as long as twelve hours. During each time span, five milliliters of the example were taken out with the end goal of the exploration, and simultaneously, five milliliters of new dissolving medium were acquainted all together with keep the sink condition. After the examples were taken out, they were properly weakened, and the absorbance was estimated utilizing spectrophotometry at a frequency of 215nm.²⁰

Kinetics Study:

The medication discharge information were fitted to three unique models: zero request (combined level of medication discharge versus time), first request (log of aggregate level of medication held versus time), and Higuchi models (combined level of medication delivered versus square foundation of time). Moreover, the Korsmeyer-Peppas model (log level of aggregate medication discharge versus log of time) was utilized to sort out the energy of medication delivery to sort out the delivery component of the medication from the arranged drifting microbeads of perindopril erbumine^20-23.

Stability Study:

The reason for security evaluation is to test a thing and furthermore to give confirmation on how the nature of a restorative item or medication fixing differs after some time affected by different ecological factors like temperature, light, and stickiness. Also, solidness testing empowers the foundation of proposed stockpiling conditions, re-trials, and time spans of usability^24-28.

RESULTS AND DISCUSSION:

Standard Calibration Curve: The standard calibration curve of perindopril erbumine was found to be in accordance with Beers Lambert's law. This was demonstrated by the fact that the equation obtained was linear, with an R2 value of 0.9972, and the equation obtained was 0.0446x-0.0375.

Micromeretic Study:

Based on the micromeretics investigation, it was evident that the created formulations exhibit a superior flow property when compared to the drug, which has an angle of repose of 49.28^o±0.25 for pure drug, whereas the beads that have been prepared exhibit a flow property of 27.57^o±0.74.

Figure 3: Standard Adjustment Bend of Perindopril Erbumine

Evaluation Parameters:

The study assessed the drug entrapment effectiveness of the manufactured beads, revealing a higher percentage yield of 82.24±0.08%. The microbeads had varying particle sizes, possibly due to human error. The drug concentration on the surface varied between 1.52 and 4.1%. The swelling index varied between 180 and 200 in 0.1N hydrochloric acid and 170 to 1760 in buffer liquid with a pH of 7.4.

Surface morphology:

An examination of the surface morphology was carried out in order to determine whether or not the microbeads were smooth or rough. The consequences of the surface morphology research showed that the dabs that were made had a round shape, yet the outer surfaces were harsh and covered with an organization of minute breaks and gaps.

Figure 4: a) Surface Morphology at 100 magnification b) Surface Morphology at 10K Magnification

Medicament Drug Release:

Drug release from fabricated microbeads lasted 12 hours. The B1-B13 formulations released 0.87-98.34% of the medication, whereas batches B14-B26 released 0.156-99.02%. This study also found that some formulations release the medicine before the needed period (8-10hours), which may be attributable to polymer content and ratios. The medication release study also found that polymer and cross-liner concentrations are crucial to drug release from any formulation. The optimal formulation was B20 since it released the most medication.

Figure 5: Percent Cumulative Drug Release of Beads for Formulations B1-B13

Figure 6: Percent Cumulative Drug Release of Beads for Formulations B14-B26

Improvisation Parameters of Beads:

Response Y1: Effect on medicament drug release: The study investigated drug discharge in two polymers, focusing on the impact of polymer focus and cross-connecting on the process. Results showed that low polymer focus resulted in unpleasant, lopsided dots, while medium and high polymer fixations produced larger, round dabs.

Improvisation Factors of Optimization 1: The study analyzed drug discharge in a prescription with a colon retention window, focusing on stomach and colon pH. Results showed minimal drug discharge with the most significant polymer focus, with higher medication discharge at lower concentrations and higher cross-connecting specialist levels.

Table 6: Test runs and noticed upsides of reactions for Box-Behnken plan

Runs	Batch	Autonomous variables			Subordinate variables
1.	B1	0	0	0	64.74	65.12
2.	B2	-1	1	0	65.01	64.76
3.	B3	1	-1	0	98.43	98.79
4.	B4	1	0	1	79.65	80.01
5.	B5	-1	0	1	51.24	50.63
6.	B6	1	1	0	97.82	98.26
7.	B7	0	1	-1	77.68	78.17
8.	B8	-1	0	-1	70.35	70.72
9.	B9	1	0	-1	94.87	95.38
10.	B10	-1	-1	0	65.25	64.71
11.	B11	0	1	1	61.04	61.59
12.	B12	0	-1	1	62.85	63.25
13.	B13	0	-1	-1	80.13	79.49

Improvisation Factors of Optimization 2:

The study reveals that polymer cross-linking with glutaraldehyde produces homogeneous beads, forming a Schiff base. However, increasing glutaraldehyde concentration does not affect drug release. The study uses a quadratic model for higher R-squared esteem. The study found that sodium alginate, Tintiri gum, and zinc sulfate interact to influence drug release, with positive numbers indicating improvement and negative values indicating opposite connections.

Table 7: Box-Behnken design experiments and response values

Runs	Batch	Independent Variables			Dependent variables
1.	B14	0	0	0	2.36	2.17
2.	B15	-1	1	0	5.17	5.42
3.	B16	1	-1	0	9.31	9.73
4.	B17	1	0	1	2.63	2.37
5.	B18	-1	0	1	2.18	2.41
6.	B19	1	1	0	4.25	4.60
7.	B20	0	1	-1	15.43	15.92
8.	B21	-1	0	-1	18.82	18.59
9.	B22	1	0	-1	17.91	18.38
10.	B23	-1	-1	0	8.58	8.22
11.	B24	0	1	1	5.41	5.18
12.	B25	0	-1	1	6.23	6.53
13.	B26	0	-1	-1	31.09	30.44

The study found that the polymer and cross-connecting specialist significantly impacted in vitro drug discharge, with a high "Absence of Fit F-esteem" attributable to commotion. The model's accuracy was satisfactory, with a Pred R-squared of 0.9599 and Adj R-squared of 0.9083.

Kinetics Study: With the guide of an energy study, the upgraded detailing was integrated into various models. The review's discoveries showed that the medication discharge from the pre-arranged globules displayed zero request energy and that, on the grounds that the worth of "n" was under 0.5, the medication discharge process followed super case II vehicle with fickian dispersion.

Table 8: Model Fitting Data for drug releases kinetics of beads.

Formulation	Zero Order	Rate Constant K’	Korsmeyers Peppas	Value of ‘n’
B20	0.923	8.890	0.957	0.491

Stability Study:

The improved formulation's cumulative drug release and % drug content were within the optimal range and were much in line with the results of the earlier preparation. In light of the information accumulated from the dependability research, it was resolved that the superior plan stayed stable during the entire review time frame and displayed no huge changes.

Table 9: Stability study data of the prepared microbeads

Room Temperature	% Drug Content	% Drug Release (After 12hrs)	Accelerated Study (40°C±2^oC/ 75 % RH ± 5% RH)	% Drug Content	% Drug Release (After 12hrs)
Day 0	92.68±0.82	99.02	Day 0	92.68±0.82	99.02
Day 15	92.68±0.82	99.02	Day 15	92.68±0.82	99.00
Day 30	92.68±1.73	98.89	Day 30	92.61±1.73	98.87
Day 45	92.51±0.24	98.88	Day 45	92.61±1.81	98.87
Day 60	92.50±1.38	98.88	Day 60	92.40±0.86	98.61
Day 90	92.50±0.74	98.87	Day 90	92.40±0.21	98.59

CONCLUSION:

The microbead design aimed to reduce patient measurements recurrence and improve prescription delivery. FT-IR and DSC studies were used to evaluate unadulterated medication and identify any manufacturing-related differences. Results showed no contradiction between medication and polymers, and the delivered dots had high flowability. B20 was found to have the highest drug discharge over a 12-hour period, making it the ideal plan. Soluble media improved prescription delivery, and glutaraldehyde was the best cross-connecting agent. The plan remained stable under favorable conditions.

REFERENCES:

1. Malviya V. Preparation and evaluation of emulsomes as a drug delivery system for bifonazole. Indian Journal of Pharmaceutical Education and Research. 2021 Jan 1; 55(1):86-94.

2. Roy H, Balaiah S, Kumar TV. Design and In-vitro Evaluation of Cefuroxime axetil floating Microbeads for Treatment of acute Bacterial caused Chronic Bronchitis. Research Journal of Pharmacy and Technology. 2018; 11(6): 2276-82.

3. Chauhan SB, Singh V, Chauhan R. Enteric coated Microbeads as a Potential Delivery System for improved probiotic effect of Lactobacillus rhamnosus GG. Research Journal of Pharmacy and Technology. 2019; 12(12): 6049-56.

4. Raghuveer P, Rani AP, Desavatu M, Chaitanya AS, Srikar G. Formulation of Monodisperse Alginate (Micro) Spheres Containing Tenofovir for Extended-Release Dosage Form. Research Journal of Pharmacy and Technology. 2017; 10(4): 1070-6.

5. Malviya VR, Pande SD, Bobade NN. Preparation and evaluation of sustained release beads of zolmitriptan hydrochloride. Research Journal of Pharmacy and Technology. 2019; 12(12): 5972-6.

6. Samuel AJ, Bhise KS. Development of alginate chitosan hydrogel beads for oral delivery of rifaximin. Research Journal of Pharmacy and Technology. 2023; 16(6): 2985-90.

7. Malviya V, Ladhake V, Gajbiye K, Satao J, Tawar M. Design and characterization of phase transition system of zolmitriptan hydrochloride for nasal drug delivery system. International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN). 2020 May 31; 13(3): 4942-51.

8. Malviya V, Thakur Y, Gudadhe SS, Tawar M. Formulation and evaluation of natural gum based fast dissolving tablet of Meclizine hydrochloride by using 3 factorial design 2. Asian Journal of Pharmacy and Pharmacology. 2020; 6(2): 94-100.

9. Malviya VR, Pande SD. Road CKN. Preparation ad Evaluation of Zolmitriptan Hydrochloride Lozenge. J Pharma Res. 2019; 8(8): 624-9.

10. Malviya V, Pande S. Development and Evaluation of Fast dissolving Film of Fluoxetine hydrochloride. Research Journal of Pharmacy and Technology. 2021; 14(10): 5345-50.

11. Malviya V, Arya A, Burange P, Gajbhiye K, Rathod G, Tawar M. To evaluate the cardioprotective effect of hydroalcoholic extract of Matricaria chamomilla linn in isoproterenol induced myocardial infarction in wistar rats. Research Journal of Pharmacy and Technology. 2022; 15(9): 3887-92.

12. Yawalkar AN, Pawar MA, Vavia PR. Microspheres for targeted drug delivery-A review on recent applications. Journal of Drug Delivery Science and Technology. 2022 Sep 1; 75: 103659.

13. Hasan KF, Xiaoyi L, Shaoqin Z, Horváth PG, Bak M, Bejó L, Sipos G, Alpár T. Functional silver nanoparticles synthesis from sustainable point of view: 2000 to 2023‒A review on game changing materials. Heliyon. 2022 Dec 1; 8(12).

14. Patashnk S, Rabinovich L, Golomb G. Preparation and evaluation of chitosan microspheres containing bisphosphonates. Journal of Drug Targeting. 1997 Jan 1; 4(6): 371-80.

15. Zhang Y, Wei W, Lv P, Wang L, Ma G. Preparation and evaluation of alginate–chitosan microspheres for oral delivery of insulin. European Journal of Pharmaceutics and Biopharmaceutics. 2011 Jan 1;77(1):11-9.

16. Malviya V, Pande S. Design and Characterization of pH Dependent Phase Transition System of Almotriptan Malate for Nasal Drug Delivery System by Employing Factorial Design. Ind. J. Pharm. Edu. Res. 2024 Jan 1; 58(1):76-90.

17. Ghosh A, Nayak UK, Roy P. Development, Evaluation and Method selection for the Preparation of lamivudine microspheres. The International Journal of Pharmaceutics. 2007 Jun; 9: 67-71.

18. Thanoo BC, Sunny MC, Jayakrishnan A. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. Journal of Pharmacy and Pharmacology. 1992 Apr; 44(4): 283-6.

19. Chandiran IS, Sivakumar T, Kumar BP. Preparation and evaluation of aceclofenac loaded biodegradable microspheres. Int J Pharm Biomed Res. 2010; 1(1): 19-23.

20. Malviya V. Investigation of in-vitro antidiabetic study, antioxidant activity and anthelminthic property of various extracts of bitter cumin seeds: antidiabetic study, antioxidant activity, and anthelminthic property of bitter cumin seeds. International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN). 2023 Jul 31;16(4):6855-74.

21. Malviya V, Tawar M, Burange P, Jodh R. A Brief Review on Resveratrol. Asian Journal of Research in Pharmaceutical Sciences. 2022 May 25;12(2):157-62.

22. Heelan BA, Corrigan OI. Preparation and evaluation of microspheres prepared from whey protein isolate. Journal of Microencapsulation. 1998 Jan 1; 15(1): 93-105.

23. Akbuǧa J, Durmaz G. Preparation and evaluation of cross-linked chitosan microspheres containing furosemide. International Journal of Pharmaceutics. 1994 Oct 27; 111(3): 217-22.

24. Milojevic S, Newton JM, Cummings JH, Gibson GR, Botham RL, Ring SG, Stockham M, Allwood MC. Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using 5-aminosalicylic acid pellets. Journal of Controlled Release. 1996 Jan 1; 38(1): 75-84.

25. Rubinstein A, Radai R, Ezra M, Pathak S, Rokem JS. In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier. Pharmaceutical Research. 1993 Feb; 10: 258-63.

26. Semde R, Amighi K, Pierre D, Devleeschouwer MJ, Moës AJ. Leaching of pectin from mixed pectin/insoluble polymer films intended for colonic drug delivery. International Journal of Pharmaceutics. 1998 Nov 15; 174(1-2): 233-41.

27. Malviya V, Tawar M, Burange P, Bairagi R. Preparation and Characterization of Gastroreten-tive Sustained Release In-situ Gel of Lafutidine. International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN). 2022 Dec 12; 15(6): 6216-28.

28. Maity SI, Mahapatra SK. Preparation and evaluation of gellan gum-linseed gum blend microbeads for sustained release of aceclofenac. Int J Appl Pharm. 2022; 14(3): 49-55.

Received on 24.07.2024 Revised on 18.10.2024

Accepted on 18.01.2025 Published on 03.03.2025

Available online from March 10, 2025

Res. J. Pharma. Dosage Forms and Tech.2025; 17(1):82-88.

DOI: 10.52711/0975-4377.2025.00012

This work is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License. Creative Commons License.

Sample	Tap Density (gm/cm³)	Bulk Density (gm/cm³)	Compressibility Index	Hauser’s Ratio	Flow Property
PE	0.591±0.72	0.389±0.04	34.08	1.52	49.28⁰±0.25
B20	0.785±0.28	0.656±0.14	16.47	1.20	27.57⁰±0.74